Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.
D000906:Antibodies / Q000032:analysis*; D001327:Autoimmune Diseases; D001681:Biological Assay; D003168:Complement Fixation Tests; D005455:Fluorescent Antibody Technique; D005500:Follow-Up Studies; D006111:Graves Disease / Q000209:etiology*; D006386:Hemagglutination Tests; D006801:Humans; D006980:Hyperthyroidism / Q000532:radiotherapy; D007037:Hypothyroidism / Q000209:etiology*; D007454:Iodides / Q000627:therapeutic use; D007456:Iodine Isotopes / Q000008:administration & dosage / Q000009:adverse effects*; D008135:Long-Acting Thyroid Stimulator / Q000096:biosynthesis* / Q000097:blood; D011830:Radiation Effects; D012964:Sodium / Q000627:therapeutic use; D013961:Thyroid Gland / Q000276:immunology* / Q000528:radiation effects; D013997:Time Factors
D000906:Antibodies; D007454:Iodides; D007456:Iodine Isotopes; D008135:Long-Acting Thyroid Stimulator; D012964:Sodium